Pembrolizumab plus platinum-based chemotherapy for unfavorable cancer of unknown primary site: Case report

INTRODUCTION: We report a case of sustained complete response in unfavorable cancer of unknown primary site (CUP) successfully treated with chemotherapy combining pembrolizumab, pemetrexed and platinum. CASE PRESENTATION: A 66-year-old man was presented with weight loss and cough for 3 months. Contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamada, Teppei, Ishiguro, Hiroshi, Okada, Shinya, Takeuchi, Hideyuki, Takahashi, Junji, Nakashima, Keigo, Nakaseko, Yuichi, Suzuki, Norihiko, Ohdaira, Hironori, Suzuki, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578551/
https://www.ncbi.nlm.nih.gov/pubmed/33101670
http://dx.doi.org/10.1016/j.amsu.2020.10.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578551/
https://www.ncbi.nlm.nih.gov/pubmed/33101670
http://dx.doi.org/10.1016/j.amsu.2020.10.024

Ejemplares similares